Key points from article :
San Francisco-based startup Mito Health raised $2.2 million in new funding, bringing its total to $4 million. The company uses AI and blood biomarker analysis to help people identify health risks early and take preventive action. Professor Brian Kennedy, a longevity expert, has joined its scientific advisory board.
Mito Health’s platform checks over 100 biomarkers linked to heart, liver, kidney, metabolic health, and nutrition. Users receive a detailed health report and long-term forecasts showing risks over 10, 20, and 30 years. Regular updates and personalized goals keep users engaged.
Mito Health also works with BodySpec and Prenuvo to include DEXA scans and preventative MRIs. According to the company, 64% of users discovered elevated health risks, 36% found vitamin deficiencies, and 4% identified critical conditions needing urgent care.
Investors include Y Combinator and Nir Eyal. Mito Health will use the funding to expand in the US and combine health data into one platform. The goal is clear: build an AI doctor that helps people live longer, healthier lives.
